Vitamin D and multiple sclerosis

作者: Sarah Hewer , Robyn Lucas , Ingrid van der Mei , Bruce V. Taylor

DOI: 10.1016/J.JOCN.2012.10.005

关键词:

摘要: The role of vitamin D supplementation in preventing multiple sclerosis (MS) and/or treating MS progression is an area significant research interest. We detail the current status ongoing this field, and note lack class 1 evidence from well-conducted, large, double-blind, placebo-controlled studies prevention treatment MS. have been able to provide some guidelines for practitioners based on substantial burden supportive use as summarised here. These may support those clinicians who treat people with their families.

参考文章(100)
Crane Je, Treatment of multiple sclerosis with fat-soluble vitamins, animal fat and ammonium chloride. Connecticut state medical journal. ,vol. 14, pp. 40- ,(1950)
Shelley Gorman, L. Alexandra Kuritzky, Melinda A. Judge, Katie M. Dixon, Jacqueline P. McGlade, Rebecca S. Mason, John J. Finlay-Jones, Prue H. Hart, Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. Journal of Immunology. ,vol. 179, pp. 6273- 6283 ,(2007) , 10.4049/JIMMUNOL.179.9.6273
Steve Simpson, Bruce Taylor, Leigh Blizzard, Anne-Louise Ponsonby, Fotini Pittas, Helen Tremlett, Terence Dwyer, Peter Gies, Ingrid van der Mei, Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Annals of Neurology. ,vol. 68, pp. 193- 203 ,(2010) , 10.1002/ANA.22043
Ai-Leng Khoo, Irma Joosten, Meta Michels, Rob Woestenenk, Frank Preijers, Xue-Hui He, Mihai G. Netea, André J. A. M. van der Ven, Hans J. P. M. Koenen, 1,25‐Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen‐presenting cells Immunology. ,vol. 134, pp. 459- 468 ,(2011) , 10.1111/J.1365-2567.2011.03507.X
L H Glimcher, E P Amento, A K Bhalla, B Serog, 1,25-dihydroxyvitamin D3 inhibits antigen-induced T cell activation Journal of Immunology. ,vol. 133, pp. 1748- 1754 ,(1984)
Vali Kermani-Arab, J. S. Adams, S. C. Jordan, A. C. Bakke, J. M. Lemire, R. Sakai, 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. Journal of Immunology. ,vol. 134, pp. 3032- 3035 ,(1985)
Mary Norval, Gary M. Halliday, The Consequences of UV‐Induced Immunosuppression for Human Health Photochemistry and Photobiology. ,vol. 87, pp. 965- 977 ,(2011) , 10.1111/J.1751-1097.2011.00969.X
Ellen M. Mowry, Lauren B. Krupp, Maria Milazzo, Dorothee Chabas, Jonathan B. Strober, Anita L. Belman, Jamie C. McDonald, Jorge R. Oksenberg, Peter Bacchetti, Emmanuelle Waubant, Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Annals of Neurology. ,vol. 67, pp. 618- 624 ,(2010) , 10.1002/ANA.21972
Reinhold Vieth, Pak-Cheung R Chan, Gordon D MacFarlane, Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level The American Journal of Clinical Nutrition. ,vol. 73, pp. 288- 294 ,(2001) , 10.1093/AJCN/73.2.288